The current mission of the AI lab for Biofabrication and Disease Modelling is to develop and implement AI-based technologies for use in microscopy, bioprinting, and automation. Patient-

derived living cell technologies play a critical role in preclinical biomedical research and may enable the development of personalized, regenerative, and curative treatments.  The combination of new emerging AI techniques in the field of computer vision and multivariate modelling, with such living cell technologies will be critical to further drive the impact of these living technologies from the fundamental to clinical domain.

AI technologies will enable the extraction of meaningful data from image-based cellular phenotypes, but also facilitate on-the-fly feedback for automation of cell assays and the bioprinting of complex multicellular 3D living constructs. The AI lab for Biofabrication and Disease Modelling will be a key infrastructure within the USP for data analysis and modelling in biology. Highly experienced AI scientists work with together with biomedical researchers to develop and apply state-of-the-art AI techniques. In addition, we focus on providing best-practices and education on the use of data and AI in fundamental and pre-clinical biology.